Banque Transatlantique SA Takes $59,000 Position in Core Natural Resources, Inc. $CNR

Banque Transatlantique SA bought a new stake in shares of Core Natural Resources, Inc. (NYSE:CNR) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 833 shares of the energy company’s stock, valued at approximately $59,000.

Other large investors have also recently modified their holdings of the company. Versant Capital Management Inc bought a new stake in shares of Core Natural Resources during the 1st quarter worth approximately $25,000. SBI Securities Co. Ltd. bought a new stake in shares of Core Natural Resources during the 1st quarter worth approximately $29,000. Farther Finance Advisors LLC bought a new stake in shares of Core Natural Resources during the 1st quarter worth approximately $30,000. Whipplewood Advisors LLC bought a new stake in shares of Core Natural Resources during the 1st quarter worth approximately $31,000. Finally, TruNorth Capital Management LLC bought a new stake in shares of Core Natural Resources during the 1st quarter worth approximately $33,000. Institutional investors own 86.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. UBS Group reissued a “buy” rating and set a $86.00 price target (up from $78.00) on shares of Core Natural Resources in a research note on Friday, August 8th. Benchmark decreased their target price on Core Natural Resources from $112.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, May 9th. Jefferies Financial Group reaffirmed a “hold” rating and set a $78.00 target price (up from $67.00) on shares of Core Natural Resources in a research report on Tuesday, August 5th. Finally, B. Riley decreased their target price on Core Natural Resources from $112.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, July 22nd. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.80.

Core Natural Resources Trading Up 6.5%

CNR opened at $75.38 on Friday. The firm has a market cap of $3.88 billion, a price-to-earnings ratio of 34.58 and a beta of 0.76. The company has a current ratio of 1.78, a quick ratio of 1.25 and a debt-to-equity ratio of 0.09. Core Natural Resources, Inc. has a 12 month low of $58.19 and a 12 month high of $134.59. The stock has a fifty day moving average price of $73.92 and a 200-day moving average price of $72.78.

Core Natural Resources (NYSE:CNR) last released its quarterly earnings results on Tuesday, August 5th. The energy company reported ($0.70) EPS for the quarter, missing the consensus estimate of $1.31 by ($2.01). The company had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.04 billion. Core Natural Resources had a return on equity of 3.01% and a net margin of 0.63%. As a group, equities research analysts anticipate that Core Natural Resources, Inc. will post 11.4 earnings per share for the current fiscal year.

Core Natural Resources Dividend Announcement

The business also recently declared a dividend, which will be paid on Monday, September 15th. Stockholders of record on Monday, September 1st will be given a $0.10 dividend. This represents a dividend yield of 56.0%. The ex-dividend date of this dividend is Friday, August 29th. Core Natural Resources’s payout ratio is presently 18.35%.

Core Natural Resources Company Profile

Core Natural Resources, Inc, together with its subsidiaries, produces and sells bituminous coal in the United States and internationally. It operates through two segments, Pennsylvania Mining Complex (PAMC) and CONSOL Marine Terminal. The company’s PAMC segment engages in the mining, preparing, and marketing of bituminous coal to power generators, industrial end-users, and metallurgical end-users.